3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
266
Lung Neoplasms
102
Adenocarcinoma of Lung
28
Mesothelioma, Malignant
24
Mesothelioma
22
Neoplasms
18
Meningeal Carcinomatosis
18
Brain Neoplasms
16
Head and Neck Neoplasms
14
Neoplasm Metastasis
13
Ovarian Neoplasms
9
NSCLC
9
Colorectal Neoplasms
8
Adenocarcinoma, Bronchiolo-Alveolar
8
Breast Neoplasms
7
Recurrence
6
Carcinoma, Transitional Cell
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma
5
Esophageal Neoplasms
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Sarcoma
4
Non-squamous Non-small Cell Lung Cancer
4
Non-small Cell Lung Cancer Metastatic
4
Fallopian Tube Neoplasms
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Pemetrexed
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled